# 1ST Source Corp: financial statements, quarterly

SRCE · Nasdaq · CIK 34782 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/srce.md) · [Financials](/companies/srce/financials.md) · [Filings](/companies/srce/filings.md) · [Insiders](/companies/srce/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/srce/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [43.2 d](/filings/0000034782-24-000033.md) | [44.6](/filings/0000034782-24-000054.md) | [47.1](/filings/0000034782-24-000092.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [8.1 d](/filings/0000034782-26-000011.md) | [8.4](/filings/0000034782-25-000045.md) | [10.9](/filings/0000034782-25-000080.md) | [10.5](/filings/0000034782-25-000109.md) | [8.6 d](/filings/0000034782-26-000011.md) | [10.2](/filings/0000034782-26-000032.md) | [10.8](/filings/0000034782-26-000045.md) | [12.7](/filings/0000034782-26-000055.md) | [12.4 d](/filings/0000034782-26-000011.md) | [11.4](/filings/0000034782-26-000032.md) | [14.1](/filings/0000034782-26-000045.md) | [14.6](/filings/0000034782-26-000055.md) |
| Net income | $m | [28.4 d](/filings/0000034782-26-000011.md) | [29.5](/filings/0000034782-25-000045.md) | [36.8](/filings/0000034782-25-000080.md) | [34.9](/filings/0000034782-25-000109.md) | [31.4 d](/filings/0000034782-26-000011.md) | [37.5](/filings/0000034782-26-000032.md) | [37.3](/filings/0000034782-26-000045.md) | [42.3](/filings/0000034782-26-000055.md) | [41.1 d](/filings/0000034782-26-000011.md) | [40.0](/filings/0000034782-26-000032.md) | [47.5](/filings/0000034782-26-000045.md) | [49.5](/filings/0000034782-26-000055.md) |
| Diluted EPS | $ per share | not reported | [1.19](/filings/0000034782-25-000045.md) | [1.49](/filings/0000034782-25-000080.md) | [1.41](/filings/0000034782-25-000109.md) | not reported | [1.52](/filings/0000034782-26-000032.md) | [1.51](/filings/0000034782-26-000045.md) | [1.71](/filings/0000034782-26-000055.md) | not reported | [1.63](/filings/0000034782-26-000032.md) | [1.95](/filings/0000034782-26-000045.md) | [2.03](/filings/0000034782-26-000055.md) |
| Basic EPS | $ per share | not reported | [1.19](/filings/0000034782-25-000045.md) | [1.49](/filings/0000034782-25-000080.md) | [1.41](/filings/0000034782-25-000109.md) | not reported | [1.52](/filings/0000034782-26-000032.md) | [1.51](/filings/0000034782-26-000045.md) | [1.71](/filings/0000034782-26-000055.md) | not reported | [1.63](/filings/0000034782-26-000032.md) | [1.95](/filings/0000034782-26-000045.md) | [2.03](/filings/0000034782-26-000055.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:ProfitLoss, us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $m | [8,728](/filings/0000034782-25-000025.md) | [8,668](/filings/0000034782-24-000054.md) | [8,878](/filings/0000034782-24-000092.md) | [8,764](/filings/0000034782-24-000114.md) | [8,932](/filings/0000034782-26-000011.md) | [8,963](/filings/0000034782-25-000045.md) | [9,087](/filings/0000034782-25-000080.md) | [9,057](/filings/0000034782-25-000109.md) | [9,055](/filings/0000034782-26-000055.md) | [9,113](/filings/0000034782-26-000032.md) | [9,263](/filings/0000034782-26-000045.md) | [9,342](/filings/0000034782-26-000055.md) |
| Total liabilities | $m | [7,660](/filings/0000034782-25-000025.md) | [7,586](/filings/0000034782-24-000054.md) | [7,763](/filings/0000034782-24-000092.md) | [7,589](/filings/0000034782-24-000114.md) | [7,750](/filings/0000034782-26-000011.md) | [7,743](/filings/0000034782-25-000045.md) | [7,830](/filings/0000034782-25-000080.md) | [7,765](/filings/0000034782-25-000109.md) | [7,737](/filings/0000034782-26-000055.md) | [7,793](/filings/0000034782-26-000032.md) | [7,910](/filings/0000034782-26-000045.md) | [7,992](/filings/0000034782-26-000055.md) |
| Short-term borrowings | $m | [312](/filings/0000034782-25-000025.md) | [250](/filings/0000034782-24-000054.md) | [288](/filings/0000034782-24-000092.md) | [166](/filings/0000034782-24-000114.md) | [249](/filings/0000034782-26-000011.md) | [61.2](/filings/0000034782-25-000045.md) | [110](/filings/0000034782-25-000080.md) | [73.6](/filings/0000034782-25-000109.md) | [239](/filings/0000034782-26-000055.md) | [289](/filings/0000034782-26-000032.md) | [199](/filings/0000034782-26-000045.md) | [234](/filings/0000034782-26-000055.md) |
| Shareholders' equity | $m | [990](/filings/0000034782-25-000025.md) | [1,010](/filings/0000034782-24-000054.md) | [1,044](/filings/0000034782-24-000092.md) | [1,104](/filings/0000034782-24-000114.md) | [1,111](/filings/0000034782-26-000011.md) | [1,161](/filings/0000034782-25-000045.md) | [1,199](/filings/0000034782-25-000080.md) | [1,236](/filings/0000034782-25-000109.md) | [1,275](/filings/0000034782-26-000055.md) | [1,278](/filings/0000034782-26-000032.md) | [1,310](/filings/0000034782-26-000045.md) | [1,320](/filings/0000034782-26-000055.md) |

- Cash and equivalents: not reported
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [44.2 d](/filings/0000034782-26-000011.md) | [42.0](/filings/0000034782-25-000045.md) | [50.0 d](/filings/0000034782-25-000080.md) | [68.4 d](/filings/0000034782-25-000109.md) | [33.5 d](/filings/0000034782-26-000011.md) | [71.8](/filings/0000034782-26-000032.md) | [44.9 d](/filings/0000034782-26-000045.md) | [51.0 d](/filings/0000034782-26-000055.md) | [55.4 d](/filings/0000034782-26-000011.md) | [59.1](/filings/0000034782-26-000032.md) | [50.8 d](/filings/0000034782-26-000045.md) | [71.1 d](/filings/0000034782-26-000055.md) |
| Capital expenditure | $m | [3.4 d](/filings/0000034782-26-000011.md) | [0.6](/filings/0000034782-25-000045.md) | [3.6 d](/filings/0000034782-25-000080.md) | [1.7 d](/filings/0000034782-25-000109.md) | [6.5 d](/filings/0000034782-26-000011.md) | [2.5](/filings/0000034782-26-000032.md) | [1.8 d](/filings/0000034782-26-000045.md) | [3.8 d](/filings/0000034782-26-000055.md) | [2.0 d](/filings/0000034782-26-000011.md) | [1.0](/filings/0000034782-26-000032.md) | [1.4 d](/filings/0000034782-26-000045.md) | [2.0 d](/filings/0000034782-26-000055.md) |
| Dividends paid | $m | [8.6 d](/filings/0000034782-26-000011.md) | [8.6](/filings/0000034782-25-000045.md) | [8.6 d](/filings/0000034782-25-000080.md) | [9.1 d](/filings/0000034782-25-000109.md) | [9.1 d](/filings/0000034782-26-000011.md) | [9.1](/filings/0000034782-26-000032.md) | [9.6 d](/filings/0000034782-26-000045.md) | [9.6 d](/filings/0000034782-26-000055.md) | [10.1 d](/filings/0000034782-26-000011.md) | [10.1](/filings/0000034782-26-000032.md) | [10.7 d](/filings/0000034782-26-000045.md) | [11.2 d](/filings/0000034782-26-000055.md) |
| Share repurchases | $m | [(0.0) d](/filings/0000034782-26-000011.md) | [0.0](/filings/0000034782-25-000045.md) | [0.0 d](/filings/0000034782-25-000080.md) | [0.0 d](/filings/0000034782-25-000109.md) | [0.2 d](/filings/0000034782-26-000011.md) | [0.5](/filings/0000034782-26-000032.md) | [2.8 d](/filings/0000034782-26-000045.md) | [6.4 d](/filings/0000034782-26-000055.md) | [4.2 d](/filings/0000034782-26-000011.md) | [23.4](/filings/0000034782-26-000032.md) | [0.0 d](/filings/0000034782-26-000045.md) | [0.0 d](/filings/0000034782-26-000055.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [24.7](/filings/0000034782-24-000054.md) | [24.7](/filings/0000034782-24-000092.md) | [24.7](/filings/0000034782-24-000114.md) | [24.5](/filings/0000034782-25-000045.md) | [24.5](/filings/0000034782-25-000080.md) | [24.5](/filings/0000034782-25-000109.md) | [24.5](/filings/0000034782-26-000032.md) | [24.5](/filings/0000034782-26-000045.md) | [24.5](/filings/0000034782-26-000055.md) | [24.3](/filings/0000034782-26-000032.md) | [24.1](/filings/0000034782-26-000045.md) | [24.1](/filings/0000034782-26-000055.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 24,084,919 at 2026-10-16, from the cover of the [10-Q filed 2026-10-22](/filings/0000034782-26-000055.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:18 ET. No prices; not investment advice.